Holst Birgitte, Elling Christian E, Schwartz Thue W
Laboratory for Molecular Pharmacology, Institute of Pharmacology, University of Copenhagen, The Panum Institute, Blegdamsvej 3, Copenhagen DK-2200, Denmark.
J Biol Chem. 2002 Dec 6;277(49):47662-70. doi: 10.1074/jbc.M202103200. Epub 2002 Sep 18.
An endogenous metal-ion site in the melanocortin MC1 and MC4 receptors was characterized mainly in transiently transfected COS-7 cells. ZnCl(2) alone stimulated signaling through the Gs pathway with a potency of 11 and 13 microm and an efficacy of 50 and 20% of that of alpha-melanocortin stimulating hormone (alpha-MSH) in the MC1 and MC4 receptors, respectively. In the presence of peptide agonist, Zn(II) acted as an enhancer on both receptors, because it shifted the dose-response curves to the left: most pronounced was a 6-fold increase in alpha-MSH potency on the MC1 receptor. The effect of the metal ion appeared to be additive, because the maximal cAMP response for alpha-MSH in the presence of Zn(II) was 60% above the maximal response for the peptide alone. The affinity of Zn(II) could be increased through binding of the metal ion in complex with small hydrophobic chelators. The binding affinities and profiles were similar for a number of the 2,2'-bipyridine and 1,10-phenanthroline analogs in complex with Zn(II) in the MC1 and MC4 receptors. However, the potencies and efficacies of the metal-ion complexes were very different in the two receptors, and close to full agonism was obtained in the MC1 receptor. Metal ion-chelator complexes having antagonistic properties were also found. An initial attempt to map the metal-ion binding site in the MC1 receptor indicated that Cys(271) in extracellular loop 3 and possibly Asp(119) at the extracellular end of TM-III, which are both conserved among all MC receptors, are parts of the site. It is concluded that the function of the MC1 and MC4 receptors can be positively modulated by metal ions acting both as partial agonists and as potentiators for other agonists, including the endogenous peptide ligand alpha-MSH at Zn(II) concentrations that could be physiological. Furthermore, the metal ion-chelator complexes may serve as leads in the development of novel melanocortin receptor modulators.
黑皮质素MC1和MC4受体中的一个内源性金属离子位点主要在瞬时转染的COS-7细胞中得到表征。单独的ZnCl₂通过Gs途径刺激信号传导,在MC1和MC4受体中的效力分别为11和13 μmol,效力分别为α-黑素细胞刺激素(α-MSH)的50%和20%。在肽激动剂存在的情况下,Zn(II)在两种受体上均作为增强剂起作用,因为它使剂量反应曲线向左移动:在MC1受体上,α-MSH效力最明显增加了6倍。金属离子的作用似乎是相加的,因为在Zn(II)存在下,α-MSH的最大cAMP反应比单独肽的最大反应高60%。通过金属离子与小的疏水螯合剂结合,可以提高Zn(II)的亲和力。在MC1和MC4受体中,许多与Zn(II)络合的2,2'-联吡啶和1,10-菲咯啉类似物的结合亲和力和图谱相似。然而,金属离子络合物在两种受体中的效力和功效非常不同,在MC1受体中接近完全激动作用。还发现了具有拮抗特性的金属离子螯合剂络合物。对MC1受体中金属离子结合位点进行定位的初步尝试表明,细胞外环3中的Cys(271)以及跨膜区III细胞外端可能的Asp(119)(在所有MC受体中均保守)是该位点的一部分。得出的结论是,MC1和MC4受体的功能可以通过金属离子作为部分激动剂以及作为其他激动剂(包括内源性肽配体α-MSH)的增强剂在可能是生理浓度的Zn(II)下起作用而得到正向调节。此外,金属离子螯合剂络合物可能成为新型黑皮质素受体调节剂开发的先导。